Graf Akcie ARCT (Arcturus Therapeutics Holdings Inc). Diskuze k akciím ARCT. Aktuální informace ARCT.

Základní informace o společnosti Arcturus Therapeutics Holdings Inc (Akcie ARCT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.24B
Hodnota podniku (EV) N/A
Tržby 8.699M
EBITDA N/A
Zisk -163.04
Růst v tržbách Q/Q -13.82 %
Růst v tržbách Y/Y -22.70 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.18
EV/Sales 122.78
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 142.15
P/FCF N/A
Price/Book 3.12
Účetní hodnota na akcii 14.97
Hotovost na akcii 17.47
FCF vůči ceně -8.09 %
Počet zaměstnanců 118
Tržba na zaměstnance 73.720k
Profit margin -756.35 %
Operating margin -1,878.45 %
Gross margin 100.00 %
EBIT margin -1,863.08 %
EBITDA margin -241.79 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 276.36 %
EPS - Očekávaný růst příští rok 72.83 %
Return on assets -37.71 %
Return on equity -49.54 %
ROIC -25.70 %
ROCE -42.87 %
Dluhy/Equity 0.20
Čistý dluh/EBITDA 19.97
Current ratio 6.19
Quick Ratio 6.19
Volatilita 6.51
Beta 1.43
RSI 49.11
Cílová cena analytiků 67
Známka akcie (dle analytiků) 1.17
Insider ownership 17.99 %
Institutional ownership 75.57 %
Počet akcií 26.327M
Procento shortovaných akcií 19.64 %
Short ratio 6.69 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie ARCT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$20.789$15.753$12.998$20.382--
Cost Of Goods Sold------
Gross Profit$20.789$15.753$12.998$20.382--
Research And Development Expenses$33.64$16.982$15.918$17.934$13.461$25.105
SG&A Expenses$12.662$20.582$7.572$3.448$4.992$5.839
Other Operating Income Or Expenses----$-1.245$-2.134
Operating Expenses$46.302$37.564$23.49$21.382$19.698$33.078
Operating Income$-25.513$-21.811$-10.492$-1$-19.698$-33.078
Total Non-Operating Income/Expense$-0.478$0.026$-0.409$-0.536$0.3$0.227
Pre-Tax Income$-25.991$-21.785$-10.901$-1.536$-19.398$-32.85
Income Taxes--$0.001$0.035$0.051$-0.017
Income After Taxes$-25.991$-21.785$-10.902$-1.571$-19.449$-32.833
Other Income------
Income From Continuous Operations$-25.991$-21.785$-10.902$-1.571$-19.449$-32.833
Income From Discontinued Operations------
Net Income$-25.991$-21.785$-10.902$-1.571$-19.449$-32.834
EBITDA$-24.829$-21.229$-10.082$-0.706$-19.647$-33.047
EBIT$-25.513$-21.811$-10.492$-1$-19.698$-33.078
Basic Shares Outstanding12103232
Shares Outstanding12103232
Basic EPS$-2.15$-2.16$-3.53$-0.77$-6.30$-16.81
EPS - Earnings Per Share$-2.15$-2.16$-3.53$-0.77$-6.30$-16.81
# 2020 2019 2018 2017 2016 2015
Current Ratio3.48393.32584.60761.411822.2569.3162
Long-term Debt / Capital0.36760.4208----
Debt/Equity Ratio0.58140.7265-0.0843--
Gross Margin100100100100--
Operating Margin-122.7236-138.4562-80.7201-4.9063--
EBIT Margin-122.7236-138.4562-80.7201-4.9063--
EBITDA Margin-119.4334-134.7616-77.5658-3.4638--
Pre-Tax Profit Margin-125.0229-138.2911-83.8667-7.5361--
Net Profit Margin-125.0229-138.2911-83.8744-7.7078--
Asset Turnover0.25310.35640.24981.4838--
Inventory Turnover Ratio------
Receiveable Turnover9.54063.515527.07925.6102--
Days Sales In Receivables38.2575103.825613.47965.0596--
ROE - Return On Equity-100.7716-159.6907-32.2602-99.6196-28.0524-164.6342
Return On Tangible Equity-100.7716-159.6906-32.2602-99.6196-28.0524-164.6342
ROA - Return On Assets-31.6412-49.2896-20.9557-11.4371-27.132-147.1144
ROI - Return On Investment-63.7237-92.4935-32.2602-99.6195-28.0524-164.6342
Book Value Per Share1.70381.27273.17140.147917.615910.1917
Operating Cash Flow Per Share1.5278-1.91281.2594.46538.6321-9.4462
Free Cash Flow Per Share1.6068-1.98771.52574.18538.614-9.4599

Porovnání s konkurencí: Akcie ARCT

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ARCT 0.00 N/A -22.70 % 72.83 % -49.54 % 3.12 -756.35 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie ARCT

Jméno Obchod Cena Objem
Pad Chivukula
Chief Scientific Officer and COO
Prodej
1 Mar 2021
$54.23 $542,300
Andy Sassine
Chief Financial Officer
Nákup
5 Dec 2019
$9.73 $54,965
Pharmaceutical Inc. Ultragenyx
Director
Option
20 May 2020
$16.00 $9,600,000
Andy Sassine
Chief Financial Officer
Nákup
10 Jun 2020
$29.74 $148,700
Joseph E Payne
President and CEO
Nákup
10 Jun 2020
$31.69 $31,690
Keith C Kummerfeld
See Remarks
Nákup
12 Jun 2020
$33.33 $14,999
Pad Chivukula
Chief Scientific Officer and COO
Prodej
3 Sep 2020
$45.16 $451,600
Pad Chivukula
Chief Scientific Officer and COO
Prodej
1 Oct 2020
$42.83 $428,300
Pad Chivukula
Chief Scientific Officer and COO
Prodej
2 Nov 2020
$55.28 $552,800
Pad Chivukula
Chief Scientific Officer and COO
Prodej
1 Dec 2020
$96.19 $961,900
Pharmaceutical Inc. Ultragenyx
Director
Prodej
8 Dec 2020
$100.81 $80,648,000
Pad Chivukula
Chief Scientific Officer and COO
Prodej
4 Jan 2021
$46.40 $464,000

Diskuze k akciím ARCT